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ABSTRACT
Microsatellite repeat and single nucleotide polymorphisms (SNPs) are abundant sources of genetic
variation, but existing methodologies cannot
simultaneously detect these variants in a facile or
inexpensive way. We describe herein a thin-film
biosensor chip based on an allele-discriminating
oligonucleotide array that enables genotyping for
both microsatellite repeats and SNPs in a single analysis. We validated this methodology for the functionally polymorphic 794 CATT5–8 repeat and 173 G/C
SNP present in the promoter of the human gene for
macrophage migration inhibitory factor (MIF ). In a
comparison of 30 samples collected at a rural hospital
in Zambia, we observed a 100% concordance for both
the CATT repeat and G/C SNP between the biosensor
methodology and the conventional capillary electrophoresis. The biosensor chips are low in cost and
once printed, they are robust and require no instrumentation for analysis. When combined with multiple
displacement amplification, this methodology can
be utilized in primitive settings for the genotyping

of nanogram quantities of DNA present in blood,
dried and stored on filter paper samples. We applied
this methodology to a field study of MIF genotype in
children with malaria, and provide first evidence for
a potential association between MIF alleles and
malaria infection. We also present data supporting
significant population stratification of the low- versus
high-expression forms of MIF that may bear on the role
of this gene in infectious diseases.

INTRODUCTION
Emerging knowledge about the association of the variant alleles of different genes with the human diseases has focused
attention on the development of technologies to rapidly
discriminate between different genotypes (1). New methods
are important, both to facilitate the acquisition of genotyping
data and to better translate this knowledge into diagnostic
and therapeutic applications. Studies of the genetics of
host immunity, for example, are revealing novel pathogenic
mechanisms that are important for understanding infectious
diseases as they affect different human populations (2,3).
Rapid and low-cost genotyping methods are especially
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Simultaneous detection of microsatellite repeats
and SNPs in the macrophage migration inhibitory
factor (MIF ) gene by thin-film biosensor chips
and application to rural field studies

e121

Nucleic Acids Research, 2005, Vol. 33, No. 13

METHODS
Patient samples
DNA specimens from normal controls of known MIF
genotype were used to develop the biosensor methodology.
Validation was performed on a random selection of DNA
specimens culled from ongoing studies of MIF genotype,
and included Caucasians, African-Americans, North East
Asians (Koreans) and the African sub-groups described in
the text. The African sub-group specimens were collected
either by K. K. Kidd and J. R. Kidd, or by one of their collaborators as part of their long-term studies on human genetic
diversity. The malaria-infected samples were obtained as part
of investigations at the Macha Mission Hospital in Choma,
Zambia, which is holoendemic for Plasmodium falciparum
malaria. These specimens consisted of blood samples that
had been spotted on filter paper, dried and stored for several
months. Parasitemia was assessed on hospital admission
by enumeration of infected red cells in thick blood smears.
All samples were obtained and utilized in accordance
with institutional and local IRB protocols. The SAS statistical
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software package was used to perform c2 analysis and
logistic regression to determine the relationship between
parasitemia and MIF genotype.
DNA extraction
Genomic DNA was isolated from patient blood or from
the blood spots dried on filter papers using the QIAamp
DNA Blood Mini kit (Qiagen, Valencia, CA) and the recommended protocols provided by the manufacturer.
DNA amplification by multiple displacement
amplification
DNA extracted from blood spots dried on filter papers was
amplified by multiple displacement amplification (MDA) (10).
The MDA reactions were performed overnight at 31 C in 50 ml
of reaction solution containing 37.5 mM Tris–HCl (pH 7.5),
50 mM KCl, 10 mM MgCl2, 5 mM (NH4)2SO4, 1 mM dNTP,
0.05 mM thiophosphate-modified random hexamer (50 NNNNsNsN), 1–5 ng genomic DNA, 0.2 U yeast pyrophosphatase and 1 U Phi29 polymerase. The products of the MDA
reaction were resolved on a 1% agarose gel stained with
ethidium bromide. The yield of amplified genomic DNA
was between 15 and 20 mg in a 50 ml reaction solution.
MIF DNA fragment amplification by PCR
Oligonucleotide primer sets were designed to amplify regions
within the MIF promoter that corresponded to DNA product
sizes of 119, 123, 127 and 131 bp for the 5-, 6-, 7- and 8-CATT
repeat polymorphisms, respectively (Table 1). An additional
set of primers was used for the 173 G/C SNP and produced
a PCR product size of 129 bp. The PCRs were carried out in
a 50 ml solution containing 1· PCR buffer (AmpliTaq Gold;
Applied Biosystem), 2.5 mM MgCl2, 0.2 mM dNTP, 10 pmol
of each forward and reverse primers, 100 ng of genomic DNA
or MDA-amplified genomic DNA and 1 U AmpliTaq Gold
DNA polymerase. For the CATT repeat, the PCR program was
as follows: 95 C for 10 min, followed by 40 cycles at 94 C for
30 s, 56 C for 30 s, 72 C for 1 min and final extension at 72 C
for 10 min, and for the 173 SNP, the PCR program was 95 C
for 10 min, followed by 40 cycles of 94 C for 30 s, 62 C for
30 s, 72 C for 1 min and final extension at 72 C for 10 min.
Oligonucleotide probe synthesis
The oligonucleotide probes were designed based on the general approach described previously (11), and with the detailed
sequence information provided in Table 1. For the CATT
repeat, the 4 P1 capture probes have 50 -aldehyde groups, 10
deoxyadenosine residues at their 50 ends and 30 bases of
upstream sequence, followed by a different number (from
1 to 4) of the CATT repeat, respectively. The P2 detection
probe contains 4 copies of CATT and 20 bases of downstream
sequence, with a biotin at its 30 end for detection and a phosphate group at its 50 end for ligation. The P1 and P2 probes
were synthesized by the Yale Keck Biotechnology Facility
at 40/50 nmol scale and were used without post-synthesis
purification. Four complementary, single-stranded artificial
targets with 5–8 copies of the AATG repeat flanked by
30 bases of the MIF promoter sequences both upstream
and downstream of the repeat motif also were synthesized.
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important for studies in the developing world, where the facilities for DNA analysis are limited and where the timely, on-site
utilization of genetic information could make an impact on
morbidity and mortality.
Our studies of polymorphisms in the gene for the cytokine,
macrophage migration inhibitory factor (MIF), and its role in
malaria infection has prompted us to develop a robust genotyping method that can be performed on-site, in rural field
settings, and at low-cost and turnaround time. MIF plays an
important role in the innate and the adaptive immune response,
and it is encoded by a functionally polymorphic gene that has
been linked to the incidence or the severity of different inflammatory conditions (4,5). These MIF alleles differ in the structure of their promoter region, which varies by the presence of a
tetranucleotide, CATT, that is repeated between 5 and 8 times
in the promoter (794 CATT5–8) (6). This repeat regulates
basal and stimulus-induced transcriptional activity, which
increases almost proportionally with repeat number in defined
in vitro assay systems. A single nucleotide polymorphism
(SNP) (173 G/C) in the MIF promoter may also influence
promoter activity, either by linkage disequilibrium or by an
interaction with the tetranucleotide site (7–9).
The close interplay between the genes of the immune
system and the host response to infection has led us to investigate the distribution of variant MIF alleles in populations, in
which different infectious diseases are endemic, with the aim
of better understanding the role of selective pressures on the
evolution of the MIF locus. Toward this end, we have developed and implemented a thin-film optical biosensor chip for
genotyping of both tetranucleotide CATT repeats and SNPs
in a single analysis that greatly facilitates the examination of
small quantities of DNA obtained in the field. These chips are
based on an allele-discriminating oligonucleotide array that
provides a direct visual readout of the different MIF promoter
polymorphisms. We document, herein, the application of this
technology to the analysis of MIF gene polymorphisms in
dried blood spots collected in a rural hospital where malaria
is endemic.
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Table 1. Oligonucleotide sequences of capture probe P1, detection probe P2, synthetic targets and PCR primers
CATT repeat
Capture probe P1

Synthetic target

PCR primer and product

SNP173 G/C
Capture probe P1

Detection probe P2
Synthetic target

PCR primer and product

P1-G
50 -CHO-AAAAAAAAAACCGGAACAGGCCGATTTCTAGCCGCCAAGTGGAGAACAGG
P1-C
50 -CHO-AAAAAAAAAACCGGAACAGGCCGATTTCTAGCCGCCAAGTGGAGAACAGC
P2 biotin
50 -phosphate-TTGGAGCGGTGCGCCGGGCTTA-biotin-30
MIF173 Target G
AGCCCGGCGCACCGCTCCAACCTGTTCTCCACTTGGCGGCTAGAAATCGGCCTGTTCCGG
MIF173 Target C
AGCCCGGCGCACCGCTCCAAGCTGTTCTCCACTTGGCGGCTAGAAATCGGCCTGTTCCGG
MIF173 Forward
ACTAAGAAAGACCCGAGGCG
MIF173 Reverse
GCAGGACCCTGGGCGACT
PCR product 129 bp
ACTAAGAAAGACCCGAGGCGAGGCCGGAACAGGCCGATTTCTAGCCGCCAAGTGGAGAA
CAGGTTGGAGCGGTGCGCCGGGCTTAGCGGCGGTTGCTGGAGGAACGGGCGGAGTCGCCCAGGGTCCTGC

The underlined sequences designate the unique repeated sequences (5–8 repeats) present in the synthetic oligonucleotide target. The bolded residue designates
the –173 G/C SNP.

Detection of MIF CATT repeat polymorphism and
173 G/C SNP on thin-film biosensor chips
The MIF CATT repeat polymorphism and the 173 G/C SNP
detection are performed by modifying solid-phase techniques
described previously (11). The P1 capture probes are manually
spotted in a format shown in Figure 1B on hydrazinefunctionalized, thin-film biosensor chips (Thermo Electron,
Louisville, CO) using 0.3 ml of 1 mM P1 in 0.1 M phosphate
buffer, pH 7.8 and 10% glycerol. After incubation for 2 h at
room temperature in a humid chamber, the chips are washed
with 0.1% SDS at 60 C for 30 min, rinsed with water and
dried. A ligation mixture containing 20 mM Tris–HCl, pH 8.3,
25 mM KCl, 10 mM MgCl2, 0.5 mM NAD, 0.01% Triton X100, 5 mg/ml acid-treated casein, 10% formamide and 0.04 U/
ml mutant Ampligase (Lys294Arg of Thermus thermophilus
ligase) is applied to each chip and prewarmed to 60 C.

The synthetic targets or MIF PCR amplicons from patient
samples at a concentration of 100 fmol in 10 ml water are
denatured at 95 C for 3 min in the presence of 100 fmol of
the P2-biotin probe. After denaturation, 10 ml of this solution is
immediately added to the pre-incubated ligation mixture and
incubated at 60 C for 20 min. A stringent wash with 0.01 M
NaOH at 60 C is applied three times, and this is followed by
briefly rinsing three times with 0.1· standard saline citrate
(SSC) at room temperature. The chips are then incubated at
room temperature for 10 min with 100 ml of an anti-biotin–
IgG–horseradish peroxidase conjugate (Jackson ImmunoResearch Lab; 1:1000 dilution from a 1 mg/ml stock in a
buffer containing 5· SSC and 5 mg/ml acid-treated casein).
After briefly washing three times with 0.1· SSC, 100 ml of a
tetramethyl benzidine formulation from BioFX Lab is added to
the chips and incubated for 5 min at room temperature, then
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Detection probe P2

P1-CATT-1
50 -CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATT
P1-CATT-2
50 -CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATTCATT
P1-CATT-3
50 -CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATTCATTCATT
P1-CATT-4
50 -CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATTCATTCATTCATT
P2 biotin
50 -phosphate-CATTCATTCATTCATTCAGCAGTATTAGTCAATGTC-biotin-30
Target AATG-5
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGGGTGAAAGAAGATAAGCCATG
ACATAGCAG
Target AATG-6
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGAATGGGTGAAAGAAGATAAGC
CATGACATAGCAG
Target AATG-7
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGAATGAATGGGTGAAAGAAGAT
AAGCCATGACATAGCAG
Target AATG-8
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGAATGAATGAATGGGTGAA
AGAAGATAAGCCATGACATAGCAG
Forward primer: CTATGTCATGGCTTATCTTC
Reverse primer: TCCACTAATGGTAAACTCGG
PCR products: 119, 123, 127 or 131
CTATGTCATGGCTTATCTTCTTTCACC(CATT)5–
8CAGCAGTATTAGTCAATGTCTCTTGATATGCCTGGCACCTGCTAGATGGTCCCCGAGTTTAC
CATTAGTGGA
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rinsed with ddH2O and air dried. The CATT and SNP polymorphisms are scored visually and the results are recorded by
imaging under a dissection microscope fitted with a digital
camera.

Figure 1 illustrates the hybridization and ligation-based
detection strategy of the biosensor methodology used for
detecting the MIF promoter CATT repeat, which is present
in a copy number of 5–8, and the 173 G/C SNP. Of importance, prior ligation-based assays have been found to be efficient only for discriminating polymorphic alleles of short
microsatellite repeats <30 bases (11,12). Ligation of longer
repeats lacks specificity because of the looping out of repeat
units in the probe/target hybrids. The loopout often occurs in
an area outside of the ligase footprint that can span 26–30
bases (12). To avoid the formation of loopouts in the MIF
CATT repeat sequence, we divided the repeat into the capture
probes ‘P1’, with CATT 1, 2, 3 or 4, and ‘P2’, with CATT4
(Figure 1A), thereby ensuring that the ligase footprint covers
6–7-CATT repeat units. Four capture probes with 1, 2, 3 and

8

4 CATT repeat units, respectively, together with 30 bases of
the upstream adjacent unique MIF sequence (see detailed
sequences in Table 1) are covalently arrayed by the reaction
between an aldehyde group at their 50 -termini and the hydrazine group on the chip surface. A detection probe, P2, with
4 copies of the CATT unit and 20 bases of the downstream
adjacent and unique MIF sequence carries a biotin at the 30 end
for detection and a phosphate at its 50 end for ligation. When
target DNA with a variable number of the CATT unit (from
5 to 8, e.g. the 6-CATT shown in Figure 1A), is hybridized
with the P1 and P2 probes on the chip surface in the presence
of a thermostable DNA ligase, the enzyme selects only
perfectly matched P1+P2/target for ligation. This reaction
results in the immobilization of the biotinylated P2 probe at
the matched P1 probe position on the chip surface. After a
stringent wash to remove all non-ligated molecules, a biotinassociated detection procedure is applied to generate a color
that can be visualized by the unaided human eye. The biochips
can also be printed by high-throughput ‘spotting’ of the requisite capture probes onto hydrazine-functionalized thin-film
biosensor chips. The entire methodology is low in cost and
once printed, the chips are robust and require no instrumentation for analysis.

B

A

Biochip Template
+
5

6

7

8

5

6

7

8

G

G

C

C

7 mm

C

55/GG

56/GG

56/GC

66/GG

66/GC

57/GC

67/GC

67/CC

77/CC

78/CC

Figure 1. (A) Schematic representation for the detection of the MIF CATT tetranucleotide repeat by ligation of biotinylated detection probe P2 to a set of capture
probes P1 with different copies of CATT repeat immobilized on thin-film biosensor chip surface in the presence of certain CATT target (i.e. CATT 6). (B) Array
template for the detection of the 5-, 6-, 7- and 8-CATT repeats, and the 173 G/C SNP. Oligonucleotides are arrayed in duplicates, as shown. +: positive control, an
aldehyde modified dA20-biotin probe. (C) Visual appearance of the biochip arrays of the representative MIF genotypes.
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Table 2. Comparison of MIF genotypes of the CATT tetranucleotide repeat and
the 173 G/C SNP in a selection of human DNA samples by optical biosensor
chip and capillary electrophoresis
Sample ID

0009
0010
0013
0014
0015
0132
0134
0209
0306
0422
0425
0428
0429
0431
0506
0507
0602
0603
0807
1003
1203
1206
1207
1308
1418a
1603
1606
0036
0914
1214

CATT repeat
Capillary
electrophoresis
5/6
6/6
6/6
5/5
6/7
5/5
5/5
5/6
5/6
5/6
5/7
6/6
5/7
5/6
6/6
6/7
7/7
5/6
6/7
6/6
6/6
6/6
6/6
5/6
5/8a
6/6
5/6
7/7
7/8
6/7

Optical
biosensor
chip
5/6
6/6
6/6
5/5
6/7
5/5
5/5
5/6
5/6
5/6
5/7
6/6
5/7
5/6
6/6
6/7
7/7
5/6
6/7
6/6
6/6
6/6
6/6
5/6
5/7a
6/6
5/6
7/7
7/8
6/7

173 G/C SNP
Capillary
electrophoresis
G/G
G/G
G/G
G/G
C/G
G/G
G/G
G/G
G/G
G/G
G/C
G/G
G/C
G/G
G/G
C/C
C/C
G/C
G/C
G/G
G/G
G/C
G/C
G/G
G/C
G/G
G/G
C/C
C/C
C/C

Optical
biosensor
chip
G/G
G/G
G/G
G/G
C/G
G/G
G/G
G/G
G/G
G/G
G/C
G/G
G/C
G/G
G/G
C/C
C/C
G/C
G/C
G/G
G/G
G/C
G/C
G/G
G/C
G/G
G/G
C/C
C/C
C/C

Different samples were first typed by biosensor chip methodology, and then
verified by capillary electrophoresis and pyrosequencing.
a
A discrepancy reading between optical biosensor chip and capillary
electrophoresis.

To test for the accuracy of genotyping the CATT repeat
polymorphism and the 173 SNP simultaneously by the
biosensor chip, we analyzed an initial 30 genomic DNA
samples that had been previously studied for MIF genotype.
In our standard methodology, the CATT repeat polymorphism
is detected by capillary electrophoresis of PCR products
amplified to span the tetranucleotide region, and the
173 G/C SNP is determined by the ddNTP primer extension
method and capillary electrophoresis, or by pyrosequencing
(6). The typings of the CATT repeat and 173 SNP obtained
by using the biosensor methodology were compared initially
in a blinded fashion. Representative images are shown in
Figure 1C and the optical biosensor genotypes are listed in
Table 2. There was complete concordance of the 173 G/C
SNP genotypes between the two methods. We observed one
discrepancy for a previously analyzed DNA sample bearing
the 8-CATT repeat. The initial chromatographic analysis for
sample 1418 showed that one PCR product peak eluted in an
intermediate position for that expected is either the 7-CATT or
the 8-CATT repeat. The peak was scored as ‘8-CATT’ by the
capillary electrophoresis (5/8), but 7-CATT by the biosensor
chip (5/7). Subsequent reanalysis of this DNA sample by capillary electrophoresis verified the presence of 7-CATT and the
scoring of this sample as ‘5/7’. The concordance with typing
data for the 173 G/C SNP and the ability to identify errors
in the CATT repeat obtained by capillary electrophoresis
indicate that genotyping by optical biosensor chips is highly
accurate.
As one phase of an ongoing project to study the association
between MIF polymorphisms and severe malarial disease, we
plan to genotype several hundred DNA specimens obtained
in rural field settings. Finger stick blood samples are
routinely collected and dried onto filter papers at local hospitals and stored on-site under ambient conditions. Limited
amounts of genomic DNA are present in these bloodspotted filter papers, and a pre-amplification step, typically
by MDA technology (10), allows these precious samples to
be used for hundreds of PCRs. To evaluate concordance
between MDA products and unamplified genomic DNA for
the ligation-based optical biosensor methodology, the 30 samples genotyped in the previous experiment were re-evaluated
after MDA. Complete fidelity was observed between the
unamplified genomic DNA and the MDA products for both
the MIF CATT polymorphism and the 173 G/C SNP genotype. It is important to point out that with respect to the applicability of this method to other genes, some sequences may
not be amenable to genotyping if they reside in repeated

Table 3. Allele and genotype frequencies of the MIF polymorphisms in Caucasian and African populations
MIF polymorphism

Genotype, frequency no. (%)

CATT(5–8)
Caucasiana (n ¼ 159)
Zambia malaria (n ¼ 40)
African control groups (n ¼ 40)
173 SNP G/C
Caucasianb (n ¼ 88)
Zambia malaria (n ¼ 40)
African control groups (n ¼ 40)

5/5
8 (5.0)
14 (35.0)
5 (12.5)
G/G
67 (76.1)
12 (30.0)
6 (15.0)

a

Data cited from Baugh et al.(6).
Data cited from Donn et al.(8).

b

5/6
61 (38.3)
14 (35.0)
19 (47.5)
G/C
21 (23.9)
12 (30.0)
19 (47.5)

Allele frequency (%)
5/7
10 (6.3)
3 (7.5)
4 (10.0)
C/C
0 (0)
16 (40.0)
15 (37.5)

6/6
53 (33.3)
5 (12.5)
5 (12.5)

6/7
25 (15.7)
1 (2.5)
7 (17.5)

7/7
0 (0)
3 (7.5)
0 (0)

5
27.3
56.3
41.3
G
88.1
45.0
38.7

6
60.3
31.2
45.0
C
11.9
55.0
61.3

7
11.0
12.5
13.7
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Using single-strand synthetic targets with tetranucleotide
repeats of 5, 6, 7 or 8 AATG, we first tested the detection
specificity for the different MIF CATT repeat sequences. A
modified ligation condition with 10% formamide in the standard ligation mixture (11) gave unambiguous discrimination
of the CATT repeat copy number. The allele-specific ligation
strategy was also used for the simultaneous detection of the
MIF SNP G/C 173.
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<10 000
>10 000

27 (84.4)
5 (15.6)

P-value

5 (71.4)
2 (28.6)

0.04

5 ¼ low-expression 5-CATT MIF allele; X ¼ higher expression 6-, 7- or
8-CATT MIF alleles.

Table 5. Compilation of MIF allele frequencies for the CATT repeat in different population groups determined by both biochip and standard methodologies

Zambia
N. Africa
NE Asia
Caucasian
African Am.

5/5 (%)

5/6 (%)

5/7 (%)

5/8 (%)

6/6 (%)

6/7 (%)

6/8 (%)

7/7(%)

5/5 +5/X(%)

X/X (%)

N

52
3
18
37
31

86
17
31
185
73

6
2
13
49
22

2 (1.1)
—
—
1 (0.2)
1 (0.5)

18
4
25
243
45

18
5
12
69
35

—
—
—
—
2 (0.9)

6
3
1
13
4

146
22
62
272
127

42
12
38
325
86

188
34
100
597
213

(27.6)
(8.8)
(18)
(6.2)
(14.5)

(45.7)
(50)
(31)
(30.9)
(34.2)

(3.2)
(5.9)
(13)
(8.2)
(10.3)

(9.6)
(11.7)
(25)
(40.6)
(21.4)

(9.6)
(14.7)
(12)
(11.5)
(16.4)

(3.2)
(8.8)
(1)
(2.1)
(1.9)

N. Africa, North African; NE Asia, Korean; African Am., African-American; X: 6-, 7- or 8-CATT MIF allele.

X
46%

X
5

46%

X

5

62% 5

X
60% 5

X
65%

5
X

78%

5

Figure 2. Distribution of MIF CATT allele frequencies in different populations superimposed on human migration patterns.

(77.7)
(64.7)
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(45.5)
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(38.0)
(54.5)
(40.3)
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Table 4. Association between parasitemia level on admission and MIF
genotype for children evaluated at the Macha Mission Hospital in Zambia
MIF genotype (n, %)
5/X
X/X

8

reaction, resulting in 15–20 mg of the MDA product per
reaction. Targets for the MIF polymorphic genotyping were
prepared by PCR of 100 ng of MDA-amplified products. The
genotyping was performed on optical biosensor chips, and the
genotypes and allele frequencies were compared with that of
a previously reported Caucasian control group (Table 3).
The initial data indicated a possible difference in the allelic
distribution of MIF genotypes in different populations.
In particular among the Zambian samples, there was a relative
increase in the proportion of the low-expression 5-CATT
allele, and a corresponding decrease in the proportion of
the high-expression 6-CATT and 7-CATT alleles when compared with the recent studies in Caucasian populations (6,13).
Furthermore, the SNP analysis revealed a relative decrease in
the 173G and a corresponding increase in the 173C in the
Zambian samples when compared with previously studied
Caucasian groups. We then analyzed small representative
sets of DNA samples obtained from four different
North African tribes and one African-American group. The
allelic distribution, when summed over the different groups,
appeared closer in distribution to the Zambian group than that

regions or are closely homologous to sequences found elsewhere in the genome, and additional optimization studies may
be necessary.
The first 40 samples from patients in Zambia with
P.falciparum malaria were collected and dried onto filter
papers, stored at ambient temperature and the genomic
DNA extracted with the QIAamp DNA Blood Mini kit
(Qiagen). DNA yields were reliably 10–20 ng per sample.
Ten nanograms of the isolated, genomic DNA was used for
whole genome amplification by MDA in a standard 50 ml

Parasitemia

OF

PAGE 7

OF

8

ACKNOWLEDGEMENTS
We thank Drs J. R. Kidd and K. K. Kidd for generously providing DNA samples from the Yoruba, Chagga, Hausa and Ibo
African tribes, which were collected by their collaborators:
Drs Sylvester L. J. Kajuna and Nganyirwa J. Karoma
(Department of Biochemistry and Molecular Biology,

e121

Hubert Kairuki Memorial University, Dar es Salaam,
Tanzania), Dr Selemani Kungulilo (Muhimbili University
College of Health Sciences, Dar es Salaam Tanzania),
Dr Adekunle Odunsi (Department of Gynecological
Oncology, Roswell Park Cancer Institute, Buffalo, NY),
Drs Friday Okonofua and F. Oronsaye (Department of
Obstetrics and Gynecology, Faculty of Medicine, University
of Benin, Benin City, Nigeria) and African-American DNA
samples from the NIGMS Human Genetic Mutant Cell
Repository, Coriell Institute for Medical Research. We thank
Dr Efim Golub for preparing mutant Ampligase and Phi29
polymerase and Dr K. K. Kidd for thoughtful discussion.
This work was supported by NIH grants 1RO1AI051306,
5RO1AI042310 and 1R01AR049610 (R.B.), 2P01GM57672
(D.C.W. and X.Z.), a Downs’s Fellowship from the Yale
School of Epidemiology and Public Health (A.B.), and grant
R11-2002-098-0000-0 from KOSEF through the Rheumatism
Research Center at Catholic University, Seoul, Korea (S.-H.P.).
A portion of these studies comprised the MPH thesis of A.B.,
which was awarded the 2005 Wilbur G. Downs International
Health Prize for the study of biochip genotyping in patients with
malaria. Funding to pay the Open Access publication charges
for this article was provided by NIH grant 1RO1AI051306
(R.B.).
Conflict of interest statement. Robert Jenison is an employee
of Thermo Electron, Corp., which provided the thin-film
biosensor chips gratis for this study. The other authors have
declared no conflicts.
REFERENCES
1. Guttmacher,A. and Collins,F.S. (2002) Genomic medicine—a primer.
N. Engl. J. Med., 347, 1512–1520.
2. Cooke,G.S. and Hill,A.V. (2001) Genetics of susceptibility to human
infectious disease. Nature Rev. Genet., 2, 967–977.
3. Dronamraju,K.R. (ed.) (2004) Infectious Disease and Host–Pathogen
Evolution. Cambridge University Press, Cambridge, UK.
4. Calandra,T. and Roger,T. (2003) Macrophage migration inhibitory factor:
a regulator of innate immunity. Nature Rev. Immunol., 3, 791–800.
5. Gregersen,P. and Bucala,R. (2003) Macrophage migration inhibitory
factor, MIF alleles, and the genetics of inflammatory disorders:
incorporating disease outcome into the definition of phenotype.
Arthritis Rheum., 48, 1171–1176.
6. Baugh,J.A., Chitnis,S., Donnelly,S.C., Monteiro,J., Lin,X., Plant,B.J.,
Wolfe,F., Gregersen,P.K. and Bucala,R. (2002) A functional promoter
polymorphism in the macrophage migration inhibitory factor (MIF) gene
associated with disease severity in rheumatoid arthritis. Genes Immun.,
3, 170–176.
7. De Benedetti,F., Meazza,C., Vivarelli,M., Rossi,F., Pistorio,A., Lamb,R.,
Lunt,M., Thomson,W., Ravelli,A., Donn,R. and Martini,A.British
Paediatric Rheumatology Study Group (2003) Functional and prognostic
relevance of the 173 polymorphism of the macrophage migration
inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
Arthritis Rheum., 48, 1398–1407.
8. Donn,R., Alourfi,Z., De Benedetti,F., Meazza,C., Zeggini,E., Lunt,M.,
Stevens,A., Shelley,E., Lamb,R., Ollier,W.E. et al. (2002) Mutation
screening of the macrophage migration inhibitory factor gene: positive
association of a functional polymorphism of macrophage migration
inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum.,
46, 2402–2409.
9. Donn,R.P., Shelley,E., Ollier,W.E. and Thomson,W.British Paediatric
Rheumatology Study Group (2001) A novel 50 -flanking region
polymorphism of macrophage migration inhibitory factor is associated
with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum., 44,
1782–1785.
10. Dean,F.B., Hosono,S., Fang,L., Wu,X., Faruqi,A.F., Bray-Ward,P.,
Sun,Z., Zong,Q., Du,Y., Du,J. et al. (2002) Comprehensive human

Downloaded from https://academic.oup.com/nar/article-abstract/33/13/e121/1094867 by Intarcia Therapeutics, Inc. user on 19 July 2019

described previously in Caucasian groups (included in
Table 3) (6,13).
With respect to clinical malaria infection, the small number
of samples from Zambia did not permit us to make any meaningful determinations with respect to MIF alleles and disease
complications or severity. Nevertheless, logistic regression
analysis revealed that patients with the 5/X genotype
(where X ¼ 6-, 7- or 8-CATT allele) were significantly less
likely to have parasitemia >10 000 than those with an X/X
genotype (P ¼ 0.04) (Table 4). Whether this finding indeed
signifies a protective effect of low-expression MIF alleles is
yet to be confirmed by larger studies. Such an association
could provide prognostic information and influence treatment
options, which frequently necessitates blood transfusions that
are costly and may carry risk of HIV or hepatitis infection.
The data suggesting ethnic variation in the allelic frequency
of the functional MIF CATT promoter polymorphism
prompted us to study additional samples, including a set of
100 control (disease-free) specimens obtained from Korea.
This analysis showed an allelic distribution that was intermediate in 5-CATT (62%, 5/5 or 5/X) and non-5-CATT (38%,
X/X) frequency when compared with the African or previously
analyzed Caucasian groups (6,13), and is in agreement
with the proportions reported in a recent study of a Japanese
population (14).
Table 5 summarizes the data that we obtained for the
frequency of the MIF alleles in different populations around
the world. By a conservative test, none of the populations
with sample size >100 deviated significantly from Hardy–
Weinberg ratios for the CATT polymorphism. Additional
studies are necessary to determine if this distribution in
CATT repeats reflect the relatedness between populations,
as may be suggested by the representation in Figure 2. Ethnic
variations in the distribution of different MIF alleles is an
important finding, given the emerging association between
these alleles and different inflammatory and infectious
diseases (5–9,13,14). Racial or geographic variations in the
population distribution of MIF alleles also suggest the possibility of different selective pressures acting on the MIF locus.
Given the high prevalence of low-expression MIF alleles
in Africa, these pressures could include historical exposure
to tropical infections such as malaria, in which MIF is believed
to play an important pathogenic role (15–17).
In conclusion, the robust optical biosensor methodology
described herein has high fidelity when compared with the
currently used methods and instrumentation, and it can be
readily combined with the MDA technique to analyze minute
quantities of DNA extracted from dried, whole blood specimens. This method will greatly facilitate the genotyping and
population studies in different field settings, and it makes
possible the rapid translation of genotyping information in
the clinic into medical intervention.

Nucleic Acids Research, 2005, Vol. 33, No. 13

e121

11.

12.

14.

genome amplification using multiple displacement amplification.
Proc. Natl Acad. Sci. USA, 99, 5261–5266.
Zhong,X.B., Reynolds,R., Kidd Jr, Kidd,K.K., Jenison,R., Marlar,R.A.
and Ward,D.C. (2003) Single-nucleotide polymorphism genotyping on
optical thin-film biosensor chips. Proc. Natl Acad. Sci. USA, 100,
11559–11564.
Zirvi,M., Bergstrom,D.E., Saurage,A.S., Hammer,R.P. and Barany,F.
(1999) Improved fidelity of thermostable ligases for detection of
microsatellite repeat sequences using nucleoside analogs.
Nucleic Acids Res., 27, e41.
Barton,A., Lamb,R., Symmons,D., Silman,A., Thomson,W.,
Worthington,J. and Donn,R. (2003) Macrophage migration inhibitory
factor (MIF) gene polymorphism is associated with susceptibility to but
not severity of inflammatory polyarthritis. Genes Immun., 4,
487–491.
Hizawa,N., Yamaguchi,E., Takahashi,D., Nishihira,J. and Nishimura,M.
(2004) Functional polymorphisms in the promoter region of macrophage

PAGE 8

OF

migration inhibitory factor and atopy. Am. J. Respir. Crit. Care Med.,
169, 1014–1018.
15. Martiney,J.A., Sherry,B., Metz,C.N., Espinoza,M., Ferrer,A.S.,
Calandra,T., Broxmeyer,H.E. and Bucala,R. (2000) Macrophage
migration inhibitory factor release by macrophages after ingestion of
Plasmodium chabaudi-infected erythrocytes: possible role
in the pathogenesis of malarial anemia. Infect. Immun., 68,
2259–2267.
16. Chaisavaneeyakorn,S., Moore,J.M., Othoro,C., Otieno,J.,
Chaiyaroj,S.C., Shi,Y.P., Nahlen,B.L., Lal,A.A. and Udhayakumar,V.
(2002) Immunity to placental malaria. IV. Placental malaria is
associated with up-regulation of macrophage migration inhibitory
factor in intervillous blood. J. Infect. Dis., 186,
1371–1375.
17. Clark,I. and Awburn,M. (2002) Migration inhibitory factor in the cerebral
and systemic endothelium in sepsis and malaria. Crit. Care Med., 30,
S263–S267.

8

Downloaded from https://academic.oup.com/nar/article-abstract/33/13/e121/1094867 by Intarcia Therapeutics, Inc. user on 19 July 2019

13.

Nucleic Acids Research, 2005, Vol. 33, No. 13

